RÉSUMÉ
AIM: The aim of this study was to determine the sagittal position of the upper incisor considering Andrews' analysis based on the position of the forehead in Peruvian individuals with different skeletal relationships. MATERIALS AND METHODS: This retrospective, cross-sectional study included 212 lateral head radiographs of Peruvian individuals (males: 85, mean age 21.38 ± 6.88, and females: 127, mean age 21.18 ± 6.95), with different skeletal relationships (Class I group = 96, Class II group = 57, Class III group = 59). The values of the ANB, SNA, SNB angles as well as the forehead anterior limit line (FALL) and goal anterior limit line (GALL) points were identified in the radiographs, and then a vertical line was drawn in each point to determine if the upper incisor was positioned forward (protruded), backward (retruded) or within (adequate) these lines. Two trained and calibrated investigators performed all the measurements. The Chi-square test was used to evaluate associations. A p-value < 0.05 was considered statistically significant. RESULTS: Overall, the sagittal position of the upper incisor showed a significant association with the sagittal skeletal relationship (p = 0.001). The upper incisors showed an adequate position (41.7%), protruded position (56.10%), and retruded position (42.40%), for Class I, II, and III skeletal relationships, respectively, as highest percentages in each Class. Statistical significance was found for females only (p = 0.005). CONCLUSION: Skeletal Class I mainly showed an adequate position of the upper central incisor, whereas for Class II a protruded position was most frequently found, and Class III presented a retruded position. CLINICAL SIGNIFICANCE: Andrews' analysis based on the position of the forehead in Peruvian individuals is a valuable tool for orthodontic diagnosis. How to cite this article: Bazán-Mendoza JR, Arias-Modesto PB, Ruíz-Mora GA, et al. Sagittal Position of the Upper Incisor in Relation to the Forehead in Peruvian Individuals with Different Skeletal Relationships. J Contemp Dent Pract 2023;24(11):821-825.
Sujet(s)
Front , Incisive , Mâle , Femelle , Humains , Adolescent , Jeune adulte , Adulte , Incisive/imagerie diagnostique , Front/imagerie diagnostique , Front/anatomie et histologie , Études rétrospectives , Études transversales , Pérou , Céphalométrie , MaxillaireRÉSUMÉ
BACKGROUND: U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausanne, Switzerland), and incobotulinumtoxinA (Xeomin; Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany). This study uses digital image correlation to compare dynamic strain reduction between available neurotoxins. METHODS: Seventy-three treatment-naive female patients aged were randomized to injection with onabotulinumtoxinA (20 units), abobotulinumtoxinA (60 units), or incobotulinumtoxinA (20 units) in the glabella. Imaging was conducted at 4, 14, and 90 days after injection. Change in average dynamic strain of the glabella was compared using ANOVA. RESULTS: At day 4, there was a 42.1 percent strain reduction in the onabotulinumtoxinA group, a 39.4 percent strain reduction in the abobotulinumtoxinA group, and a 19.8 percent strain reduction in the incobotulinumtoxinA group (onabotulinumtoxinA versus abobotulinumtoxinA, p = 0.77; onabotulinumtoxinA versus incobotulinumtoxinA, p = 0.02; and abobotulinumtoxinA versus incobotulinumtoxinA, p = 0.04). At day 14, there was a 66.1 percent strain reduction in the onabotulinumtoxinA group, a 51.4 percent strain reduction in the abobotulinumtoxinA group, and a 42.8 percent strain reduction in the incobotulinumtoxinA group (onabotulinumtoxinA versus abobotulinumtoxinA, p = 0.14; onabotulinumtoxinA versus incobotulinumtoxinA, p = 0.02; and abobotulinumtoxinA versus incobotulinumtoxinA, p = 0.36). At day 90, there was a 43.5 percent strain reduction in the onabotulinumtoxinA group, a 38.4 percent strain reduction in the abobotulinumtoxinA group, and a 25.3 percent strain reduction in the incobotulinumtoxinA group (onabotulinumtoxinA versus abobotulinumtoxinA, p = 0.66; onabotulinumtoxinA versus incobotulinumtoxinA, p = 0.12; and abobotulinumtoxinA versus incobotulinumtoxinA, p = 0.24). CONCLUSIONS: Using digital image correlation, the tested neuromodulators do not have equivalent strain reduction in the glabella at the doses used. These results confirm assertions of noninterchangeability. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
Sujet(s)
Inhibiteurs de la libération d'acétylcholine/pharmacologie , Toxines botuliniques de type A/pharmacologie , Techniques cosmétiques , Front , Traitement d'image par ordinateur , Vieillissement de la peau/effets des médicaments et des substances chimiques , Adulte , Sujet âgé , Méthode en double aveugle , Expression faciale , Femelle , Front/imagerie diagnostique , Humains , Adulte d'âge moyen , Études prospectives , Contrainte mécanique , Jeune adulteRÉSUMÉ
Cutaneous meningiomas are rare tumors most commonly located on the scalp. We report the case of a 55-year-old male who presented with a 2 x 3 cm tumoral lesion on the forehead. The lesion was hard, adherent and covered by normal skin. Incisional biopsy revealed a proliferation of monomorphic round cells, organized in nests and focally forming pseudovascular spaces. Immunohistochemical study revealed positivity for epithelial antigen membrane and vimentin. Vascular markers, cytokeratins and S100 protein were negative. A brain CT scan did not show any evidence of intracranial meningioma. The authors describe the case of a cutaneous frontal meningioma in probable relation with previous cranioencephalic trauma.
Sujet(s)
Méningiome/anatomopathologie , Tumeurs cutanées/anatomopathologie , Biopsie , Front/imagerie diagnostique , Front/anatomopathologie , Humains , Mâle , Méningiome/imagerie diagnostique , Adulte d'âge moyen , Radiographie , Tumeurs cutanées/imagerie diagnostiqueRÉSUMÉ
A young adolescent patient presented to the emergency department with forehead and eyelid swelling after a week of nasal discharge that was suspicious for Pott's puffy tumor. Point-of-care ultrasound facilitated rapid diagnosis and initiation of treatment for a concerning and rare complication of sinusitis, confirmed by computed tomography scan.
Sujet(s)
Abcès/diagnostic , Sinusite frontale/complications , Tumeur de Pott/diagnostic , Abcès/étiologie , Adolescent , Enfant , Front/imagerie diagnostique , Sinusite frontale/imagerie diagnostique , Humains , Mâle , Systèmes automatisés lit malade , Tumeur de Pott/étiologie , Tomodensitométrie , ÉchographieSujet(s)
Filamines/génétique , Front/malformations , Études d'associations génétiques , Mutation/génétique , Ostéochondrodysplasies/génétique , Adulte , Femelle , Front/imagerie diagnostique , Front/physiopathologie , Humains , Mâle , Ostéochondrodysplasies/imagerie diagnostique , Ostéochondrodysplasies/physiopathologie , Phénotype , Radiographie , Récidive , Analyse de séquence d'ADN , FratrieRÉSUMÉ
OBJECTIVE: To identify the craniofacial characteristics of patients with sickle cell trait (SCT) and sickle cell anemia (SCA) and to compare these measurements with those of nonaffected subjects. MATERIALS AND METHODS: Clinically normal patients and those with SCT and SCA were evaluated in this study. The patients were divided into three groups: normal (control), SCA, and SCT (n â=â with 15 in each group). Inclusion criteria were SCA or SCT verified by laboratory methods and no treatment with fixed orthodontics or facial orthopedics. Lateral cephalometric radiographs were carried out and were used to obtain angular and linear measurements of anatomic structures displayed. All markings and measurements were performed by a single examiner. RESULTS: The average ANB was increased in groups with SCA (5.47 ± 2.0°) and SCT (3.80 ± 1.4°), indicating a tendency to Class II. The mean SNA angle was 83.0 ± 3.8° and 82.1±3.5° for SCA and SCT, indicating a proper positioning of the jaw from the skull base. There was an interaction between the group and sex factors for the variable SN-GoGn; measures were higher for men in the SCA group. CONCLUSION: Patients with SCA and SCT exhibited characteristics of Class II skeletal pattern because of mandibular retrusion. Most patients showed no compensatory maxillary expansion, which was determined by the normal jaw length and absence of maxillary protrusion.
Sujet(s)
Drépanocytose/imagerie diagnostique , Céphalométrie/méthodes , Os de la face/imagerie diagnostique , Trait drépanocytaire/imagerie diagnostique , Crâne/imagerie diagnostique , Études transversales , Femelle , Front/imagerie diagnostique , Humains , Incisive/imagerie diagnostique , Lèvre/imagerie diagnostique , Mâle , Malocclusion de classe II/imagerie diagnostique , Mandibule/imagerie diagnostique , Maxillaire/imagerie diagnostique , Molaire/imagerie diagnostique , Os nasal/imagerie diagnostique , Orbite/imagerie diagnostique , Fosse ptérygopalatine/imagerie diagnostique , Radiographie numérisée dentaire/méthodes , Selle turcique/imagerie diagnostique , Facteurs sexuels , Base du crâne/imagerie diagnostique , Jeune adulteRÉSUMÉ
BACKGROUND: Lipomas are frequent benign soft tissue tumors. They are classified as superficial or deep. In the head, they are localized under the galea or epicraneal aponeurosis. Clinically they present as non symptomatic smooth tumors. AIM: To describe ultrasound (US) findings of subgaleal lipomas. MATERIAL AND METHODS: Retrospective review of seven patients aged between 31 and 52 years (five males) with subgaleal lipomas. RESULTS: AH lipomas were localized in the forehead. At US, they appeared as solid masses; 43% were isoechoic and 47% hyperechoic compared to subcutaneous tissue. The average size was 13 mm. They had a semi spherical shape, with a flat base and a convex surface, a regular margin, no vascular vessels at Doppler ultrasound and were surrounded by the galea. DISCUSSION: In this series of patients, all masses had a similar US appearance that suggested the diagnosis of lipoma.